Dosing Patterns of Dulaglutide and Semaglutide in Patients with Type 2 Diabetes in the United Kingdom and Germany: A Retrospective Cohort Study

INTRODUCTION: As new glucagon-like peptide 1 receptor agonist (GLP-1 RA) formulations are available, the aim of this study was to understand dulaglutide and subcutaneous (s.c.) semaglutide dosing patterns in people with type 2 diabetes mellitus (T2DM) in the UK and Germany as well as oral semaglutid...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrett, Annabel, Debackere, Nele, Ribeiro, Anderson, Keapoletswe, Karabo, Zingel, Rebecca, Coles, Briana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246869/
https://www.ncbi.nlm.nih.gov/pubmed/37286889
http://dx.doi.org/10.1007/s12325-023-02540-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246869/
https://www.ncbi.nlm.nih.gov/pubmed/37286889
http://dx.doi.org/10.1007/s12325-023-02540-y

Ejemplares similares